Vivo Capital Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Vivo Capital has acquired 1 company. It has also invested in 3 others.

Vivo Capital’s most common sectors for investment are life science (72%) and medical products (29%). The Firm’s most common investment types include venture (72%) and buyout (lbo, mbo, mbi) (8%). In total, Vivo Capital has invested in 7 US states and 4 different countries.

In the last 3 years, Vivo Capital has exited 3 companies. The Firm’s most common exit type is ipo (80%). Vivo Capital’s largest (disclosed) exit occurred in 2019 when it sold SentreHEART for $300M.

Join Mergr to view Vivo Capital’s full profile and discover more large private equity firms just like it.

M&A Summary

  • M&A Total Activity19
    • M&A Buy Activity14
    • M&A Sell Activity5
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 5

Vivo Capital

192 Lytton Avenue,
Palo Alto, California 94301
United States
(650) 688-0818
www.vivocapital.com
info@vivocapital.com

Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1997 and is headquartered in Palo Alto, California.


Investment Criteria

Sectors of Interest: Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Asia/Pacific

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (1.4/yr) # 7 3 3 1 - - 14
Sell (0.6/yr) # 2 - 1 1 1 - 5
vol $300M $300M
  19

Most Recent M&A

Company Date Value Type
SentreHEART, Inc. 2019-08-12 300M USD Add-on Acquisition
Redwood City, California · www.sentreheart.com
VISEN Pharmaceuticals 2018-11-08 - Joint Venture
, China
Tricida, Inc. 2018-06-02 - IPO
South San Francisco, California · www.tricida.com
Outpost Medicine LLC 2017-11-15 - Venture
Indianapolis, Indiana · www.outpostmedicine.com
Apellis Pharmaceuticals, Inc. 2017-11-08 - IPO
Crestwood, Kentucky · www.apellis.com
Harmony Biosciences LLC 2017-10-06 - Venture
Plymouth Meeting, Pennsylvania · www.harmonybiosciences.com
Apellis Pharmaceuticals, Inc. 2017-08-10 - Venture
Crestwood, Kentucky · www.apellis.com
Angiotech Pharmaceuticals, Inc. 2016-12-19 - Buyout (LBO, MBO, MBI)
Vancouver, British Columbia · www.angiotech.com
Impel NeuroPharma, Inc. 2016-12-02 - Venture
Seattle, Washington · www.impelnp.com
Kala Pharmaceuticals, Inc. 2016-04-13 - Venture
Watertown, Massachusetts · www.kalarx.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 6 (67%) - 10 (71%) -
Medical Products 3 (33%) - 4 (29%) -
Total 9 - 14 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (78%) - 11 (79%) -
  California 1 (11%) - 4 (29%) -
  Pennsylvania 2 (22%) - 2 (14%) -
  Washington 1 (11%) - 1 (7%) -
  Ohio 1 (11%) - 1 (7%) -
  Massachusetts 1 (11%) - 1 (7%) -
  Indiana 1 (11%) - 1 (7%) -
  Kentucky - - 1 (7%) -
Canada 1 (11%) - 1 (7%) -
  British Columbia 1 (11%) - 1 (7%) -
China 1 (11%) - 1 (7%) -
Ireland - - 1 (7%) -
Total 9 - 14 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 5 (56%) - 10 (71%) -
Buyout (LBO, MBO, MBI) 1 (11%) - 1 (7%) -
Joint Venture 1 (11%) - 1 (7%) -
PIPE 1 (11%) - 1 (7%) -
Stake Purchase 1 (11%) - 1 (7%) -
Total 9 - 14 -

Exits by Deal Type

Type Total # Value
IPO 4 (80%) -
Trade Sale - Public Company 1 (20%) 300M (100%)
Total 5 $300M

Deal Values

sell # Total
$100M to $1B 1 $300M
TOTAL $300M
Largest SentreHEART, Inc.
$300M (2019-08-12)

M&A Connections

Deals %
Exited to
Strategic(s)
100%
1 100%

 Subscribe to unlock this and 155,592
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 44K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.